Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:17:49.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the NIH websites transition.
    Difference
    0.4%
    Check dated 2026-10-24T13:58:41.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:51:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T14:55:54.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new record history entry 'Revision: v3.7.0' was added to the history, and the prior entry 'Revision: v3.6.6' was removed, updating the study's version history list.
    Difference
    0.1%
    Check dated 2026-09-19T19:30:18.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The record history now displays a new revision entry labeled v3.6.6. The previous revision v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:07.000Z thumbnail image

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.